Bavandi, A <br/><br/>
Pimecrolimus and tacrolimus differ in their inhibition of lymphocyte activation during the sensitization phase of contact hypersensitivity.  [electronic resource] 

 -  Journal of dermatological science  Aug 2006 
 - 117-26 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0923-1811 
<br/><br/><label>Standard No.: </label>10.1016/j.jdermsci.2006.04.001  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>CD11c Antigen--analysis<br/>Dermatitis, Contact--immunology<br/>Flow Cytometry<br/>Immunosuppressive Agents--pharmacology<br/>Lymph Nodes--immunology<br/>Lymphocyte Activation--drug effects<br/>Mice<br/>Tacrolimus--analogs & derivatives